Moderna announced Tuesday morning that it has begun dosing patients in a mid-to-late stage study of its coronavirus vaccine in children aged six months to less than 12 years old.
Fuente: Youtube
Moderna announced Tuesday morning that it has begun dosing patients in a mid-to-late stage study of its coronavirus vaccine in children aged six months to less than 12 years old.
Fuente: Youtube
